Cargando…

Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling

Accurate estimation of cancer risk in HBOC families often requires BRCA1/2 testing, but this may be impossible in deceased family members. Previous, testing archival formalin-fixed, paraffin-embedded (FFPE) tissue for germline BRCA1/2 variants was unsuccessful, except for the Jewish founder mutation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petersen, Annabeth Høgh, Aagaard, Mads Malik, Nielsen, Henriette Roed, Steffensen, Karina Dahl, Waldstrøm, Marianne, Bojesen, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970683/ https://www.ncbi.nlm.nih.gov/pubmed/26733283 http://dx.doi.org/10.1038/ejhg.2015.268

Ejemplares similares

The Prevalence of Pathogenic or Likely Pathogenic Germline Variants in a Nationwide Cohort of Young Colorectal Cancer Patients Using a Panel of 18 Genes Associated with Colorectal Cancer
por: Frostberg, Erik, et al.
Publicado: (2021)

Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples
por: Enyedi, Márton Zsolt, et al.
Publicado: (2016)

The repertoire of germline variants in patients with early‐onset rectal cancer
por: Beltrami, Caroline Moraes, et al.
Publicado: (2022)

A critical spotlight on the paradigms of FFPE-DNA sequencing
por: Steiert, Tim A, et al.
Publicado: (2023)

Immunohistochemical Expression of Platelet-Derived Growth Factor Receptors in Ovarian Cancer Patients with Long-Term Follow-Up
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer
por: Carvalho, Robson Francisco, et al.
Publicado: (2022)

Transcriptome Profiling of Archived Sectioned Formalin-Fixed Paraffin-Embedded (AS-FFPE) Tissue for Disease Classification
por: Kojima, Kensuke, et al.
Publicado: (2014)

SimFFPE and FilterFFPE: improving structural variant calling in FFPE samples
por: Wei, Lanying, et al.
Publicado: (2021)

Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE Sections
por: Marton, Matthew J., et al.
Publicado: (2015)

Epigenomic profiling of archived FFPE tissues by enhanced PAT-ChIP (EPAT-ChIP) technology
por: Amatori, Stefano, et al.
Publicado: (2018)

RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery
por: Pennock, Nathan D., et al.
Publicado: (2019)

High quality and quantity Genome-wide germline genotypes from FFPE normal tissue
por: Cannon-Albright, Lisa A, et al.
Publicado: (2011)

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2010)

Sustainable business: integrating CSR in business and functions
por: Aagaard, Annabeth
Publicado: (2016)

Digital business models: driving transformation and innovation
por: Aagaard, Annabeth
Publicado: (2019)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer
por: STEFFENSEN, KARINA DAHL, et al.
Publicado: (2016)

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
por: Henriksen, Jon Røikjær, et al.
Publicado: (2020)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer
por: Faaborg, Louise, et al.
Publicado: (2022)

Evaluation of Protein Purification Techniques and Effects of Storage Duration on LC-MS/MS Analysis of Archived FFPE Human CRC Tissues
por: Rossouw, Sophia C., et al.
Publicado: (2021)

Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples
por: Zakrzewski, Falk, et al.
Publicado: (2019)

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
por: Purnomosari, Dewajani, et al.
Publicado: (2007)

Germline FFPE inherited cancer panel testing in deceased family members: implications for clinical management of unaffected relatives
por: Bennett, Sarah, et al.
Publicado: (2021)

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial
por: Aghajanian, Carol, et al.
Publicado: (2022)

Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAness
por: Andersen, Lars v. B., et al.
Publicado: (2023)

Germline retinoblastoma: estimating risk and counselling the family
por: Rosser, Elisabeth, et al.
Publicado: (2018)

Germline testing and genetic counselling in prostate cancer
por: Russo, Jessica, et al.
Publicado: (2022)

Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues
por: Civita, Prospero, et al.
Publicado: (2019)

Evaluation of models to predict BRCA germline mutations
por: Kang, H H, et al.
Publicado: (2006)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

Serial measurements of serum PDGF-AA, PDGF-BB, FGF2, and VEGF in multiresistant ovarian cancer patients treated with bevacizumab
por: Madsen, Christine Vestergaard, et al.
Publicado: (2012)

Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer
por: Korlimarla, Aruna, et al.
Publicado: (2016)

DeepSAGE—digital transcriptomics with high sensitivity, simple experimental protocol and multiplexing of samples
por: Nielsen, Kåre L., et al.
Publicado: (2006)

Fibroblast activating protein-α expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques
por: Tabola, Renata, et al.
Publicado: (2017)

Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
por: Henouda, Sarra, et al.
Publicado: (2016)

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016)

BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
por: Vos, Shoko, et al.
Publicado: (2017)

Melanoma predisposition—A limited role for germline BRCA1 and BRCA2 variants
por: Adams, David J., et al.
Publicado: (2019)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s0u2offh6jl27breaha93gjb7j